A strong risk management strategy is what drives chief medical officer Alan Harmatz, MD, of Medical City Dallas. It's a key component of his job for delivering high-quality care for patients.

» Operational risk The logistical and management challenges involved in delivering robust clinical information about a candidate drug to the right sources, in a timely manner » Resource risk Exposures ...

We’re in the midst of a paradigm shift in biomarker science. | The right biomarker signature can de-risk trials, guide ...

Increasing adoption of risk-based quality management Thanks to both COVID-19 pandemic restrictions and technological advancements, the remote risk monitoring process has garnered more attention ...

Risk-based quality management, or RBQM, is the process by which pharmaceutical organizations monitor and manage quality throughout clinical trials. By Gayle Hamilton and Adrian Kizewski on April ...

In January 2020, the Food and Drug Administration (FDA) issued a guidance entitled Chemistry, Manufacturing, and Control (CMC) Information for Human Gene Therapy Investigational New Drug Applicatio ...

Adam Ennamli is Chief Risk Officer at General Bank of Canada & former VP O&T at Thomson Reuters. Global Board advisor on strategy and risk. Many organizations invest heavily in risk management ...

Risk management should not just be a checklist to be compliant. Rather, it should be a source of value, inextricably tied to your business strategy. Purpose-driven and customer-centric risk ...